Trials / Completed
CompletedNCT02475564
Resveratrol for Pain Due to Endometriosis
The Use of Resveratrol for Pain in Endometriosis - A Clinical Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Academic / Other
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to verify whether the use of 40 mg of resveratrol per day associated with monophasic contraceptive pill (levonorgestrel 0.15mg/ethinyl estradiol 0.03mg) reduces pelvic pain at the end of 2 months of treatment, compared to the use of the pill with placebo.
Detailed description
Endometriosis is a disease that affects 176 million women around the world, and it is present in about 60% of adolescent women with chronic pelvic pain and dysmenorrhea. Some researchers have investigated the antiproliferative effect of resveratrol in endometriosis using animal models and humans. The reduction in the size and activity of the endometriotic implants has been observed with the use of resveratrol. The reduction of pain in patients with endometriosis is an important aspect of the quality of life. The use of a medication with few side effects and the lack of clinical quality trials justify this study, which aims to verify whether the use of 40 mg of resveratrol per day associated with monophasic contraceptive pill reduces pelvic pain at the end of 2 months of treatment, compared to the use of the pill with placebo. This study will be randomized, prospective, double blind with two arms of 22 patients; the CONSORT parameters will be followed. The degree of pain by visual analog scale, prolactin levels (ng / mL) and the carcinoembryonic antigen levels (CA125) (IU / L) will be measured at the begging and at the end of trial. These parameters will be the outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | 40mg of starch |
| DRUG | Resveratrol | 40mg of resveratrol (powder) |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-06-18
- Last updated
- 2016-10-14
- Results posted
- 2016-08-05
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02475564. Inclusion in this directory is not an endorsement.